Alzheimer's-like signaling in brains of COVID-19 patients.

Steven ReikenLeah SittenfeldHaikel DridiYang LiuXiaoping LiuAndrew R Marks

Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)

COVID-19 neuropathology includes AD-like features and leaky RyR2 channels could be a therapeutic target for amelioration of some cognitive defects associated with SARS-CoV-2 infection and long COVID.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
cognitive decline